Top

Published in:

2019 | OriginalPaper | Chapter

8. Cellular Uptake Mechanisms and Detection of Nanoparticle Uptake by Advanced Imaging Methods

Authors : Kleanthis Fytianos, Fabian Blank, Loretta Müller

Published in: Biological Responses to Nanoscale Particles

Publisher: Springer International Publishing

Activate our intelligent search to find suitable subject content or patents.

search-config

AI-assisted search

Off

Abstract

The specific mechanism, of uptake of a nanoparticle by a cell and the subcellular localisation are of great importance regarding the potential effect of the nanomaterial inside the cell. In order to study health risks and the potential of a nanoparticle to be used in biomedical applications, cellular internalization has to be investigated in great detail. This chapter highlights most relevant routes of nanoparticle uptake and includes current approaches for the visualization of particle uptake at the nano-level.

Dont have a licence yet? Then find out more about our products and how to get one now:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

über 102.000 Bücher
über 537 Zeitschriften

aus folgenden Fachgebieten:

Automobil + Motoren
Bauwesen + Immobilien
Business IT + Informatik
Elektrotechnik + Elektronik
Energie + Nachhaltigkeit
Finance + Banking
Management + Führung
Marketing + Vertrieb
Maschinenbau + Werkstoffe
Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

inform now

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

über 67.000 Bücher
über 390 Zeitschriften

aus folgenden Fachgebieten:

Automobil + Motoren
Bauwesen + Immobilien
Business IT + Informatik
Elektrotechnik + Elektronik
Energie + Nachhaltigkeit
Maschinenbau + Werkstoffe

Jetzt Wissensvorsprung sichern!

inform now

previous chapter Cellular and Non-cellular Barriers to Particle Transport Across the Lungs

next chapter Imaging Techniques for Probing Nanoparticles in Cells and Skin

Beddoes, C.M., Case, C.P., Briscoe, W.H.: Understanding nanoparticle cellular entry: a physicochemical perspective. Adv. Colloid Interface Sci. 48–68 (2015). https://doi.org/10.1016/j.cis.2015.01.007

Abbas, K., Cydzik, I., Del Torchio, R., Farina, M., Forti, E., Gibson, N., et al.: Radiolabelling of TiO2 nanoparticles for radiotracer studies. J Nanopart. Res. 12, 2435–2443 (2010). https://doi.org/10.1007/s11051-009-9806-8CrossRef

Maynard, A.D., Aitken, R.J., Butz, T., Colvin, V., Donaldson, K., Oberdörster, G., et al.: Safe handling of nanotechnology. Nature 444, 267–269 (2006). https://doi.org/10.1038/444267aCrossRefADS

Nel, A., Xia, T., Mädler, L., Li, N.: Toxic potential of materials at the nanolevel. Science 622–627 (2006). https://doi.org/10.1126/science.1114397

Service, R.F.: Priorities needed for nano-risk research and development. Science. 45 (2006). https://doi.org/10.1126/science.314.5796.45

Barnard, A.S.: Nanohazards: Knowledge is our first defence. Nat. Mater. 5, 245–248 (2006). https://doi.org/10.1038/nmat1615CrossRefADS

Handy, R.D., Von Der Kammer, F., Lead, J.R., Hassellöv, M., Owen, R., Crane, M.: The ecotoxicology and chemistry of manufactured nanoparticles. Ecotoxicology 287–314 (2008). https://doi.org/10.1007/s10646-008-0199-8

Linse, S., Cabaleiro-Lago, C., Xue, W.-F., Lynch, I., Lindman, S., Thulin, E., et al.: Nucleation of protein fibrillation by nanoparticles. Proc. Natl. Acad. Sci. 104, 8691–8696 (2007). https://doi.org/10.1073/pnas.0701250104CrossRefADS

Lunov, O., Zablotskii, V., Syrovets, T., Röcker, C., Tron, K., Nienhaus, G.U., et al.: Modeling receptor-mediated endocytosis of polymer-functionalized iron oxide nanoparticles by human macrophages. Biomaterials 32, 547–555 (2011). https://doi.org/10.1016/j.biomaterials.2010.08.111CrossRef

10.

Lunov, O., Syrovets, T., Röcker, C., Tron, K., Ulrich Nienhaus, G., Rasche, V., et al.: Lysosomal degradation of the carboxydextran shell of coated superparamagnetic iron oxide nanoparticles and the fate of professional phagocytes. Biomaterials 31, 9015–9022 (2010). https://doi.org/10.1016/j.biomaterials.2010.08.003CrossRef

11.

Yameen, B., Choi, W.I., Vilos, C., Swami, A., Shi, J., Farokhzad, O.C.: Insight into nanoparticle cellular uptake and intracellular targeting. J Control Release. 190, 485–499 (2014). https://doi.org/10.1016/j.jconrel.2014.06.038CrossRef

12.

Treuel, L., Jiang, X., Nienhaus, G.U.: New views on cellular uptake and trafficking of manufactured nanoparticles. J. R. Soc. Interface 10, 20120939–20120939 (2013). https://doi.org/10.1098/rsif.2012.0939CrossRef

13.

AshaRani, P.V., Mun, G.L.K., Hande, M.P., Valiyaveettil, S.: Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano 3, 279–290 (2009). https://doi.org/10.1021/nn800596wCrossRef

14.

Chithrani, B.D., Ghazani, A.A., Chan, W.C.W.: Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett. 6, 662–668 (2006). https://doi.org/10.1021/nl052396oCrossRefADS

15.

Rejman, J., Oberle, V., Zuhorn, I.S., Hoekstra, D.: Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. Biochem J. 377, 159–169 (2004). https://doi.org/10.1042/bj20031253

16.

Labhasetwar, V., Song, C., Humphrey, W., Shebuski, R., Levy, R.J.: Arterial uptake of biodegradable nanoparticles: effect of surface modifications. J. Pharm. Sci. 87, 1229–1234 (1998). https://doi.org/10.1021/js980021fCrossRef

17.

Arbab, A.S., Bashaw, L.A., Miller, B.R., Jordan, E.K., Lewis, B.K., Kalish, H., et al.: Characterization of biophysical and metabolic properties of cells labeled with superparamagnetic iron oxide nanoparticles and transfection agent for cellular MR imaging. Radiology 229, 838–846 (2003). https://doi.org/10.1148/radiol.2293021215CrossRef

18.

Sun, X., Rossin, R., Turner, J.L., Becker, M.L., Joralemon, M.J., Welch, M.J., et al.: An assessment of the effects of shell cross-linked nanoparticle size, core composition, and surface PEGylation on in vivo biodistribution. Biomacromolecules 6, 2541–2554 (2005). https://doi.org/10.1021/bm050260eCrossRef

19.

Nativo, P., Prior, I.A., Brust, M.: Uptake and intracellular fate of surface-modified gold nanoparticles. ACS Nano 2, 1639–1644 (2008). https://doi.org/10.1021/nn800330aCrossRef

20.

Holzapfel, V., Lorenz, M., Weiss, C.K., Schrezenmeier, H., Landfester, K., Mailänder, V.: Synthesis and biomedical applications of functionalized fluorescent and magnetic dual reporter nanoparticles as obtained in the miniemulsion process. J. Phys. Condens. Matter. 18 (2006). https://doi.org/10.1088/0953-8984/18/38/s04

21.

Rajendran, L., Knölker, H.-J., Simons, K.: Subcellular targeting strategies for drug design and delivery. Nat. Rev. Drug Discov. 9, 29–42 (2010). https://doi.org/10.1038/nrd2897CrossRef

22.

Huang, J.G., Leshuk, T., Gu, F.X.: Emerging nanomaterials for targeting subcellular organelles. Nano Today 478–492 (2011). https://doi.org/10.1016/j.nantod.2011.08.002

23.

Kettiger, H., Schipanski, A., Wick, P., Huwyler, J.: Engineered nanomaterial uptake and tissue distribution: from cell to organism. Int. J. Nanomed. 3255–3269 (2013). https://doi.org/10.2147/ijn.s49770

24.

Aderem, A., Underhill, D.M.: Mechanisms of phagocytosis in macrophages. Annu. Rev. Immunol. 17, 593–623 (1999). https://doi.org/10.1146/annurev.immunol.17.1.593CrossRef

25.

Hillaireau, H., Couvreur, P.: Nanocarriers’ entry into the cell: relevance to drug delivery. Cell. Mol. Life Sci. 66, 2873–2896 (2009). https://doi.org/10.1007/s00018-009-0053-zCrossRef

26.

Silverstein, S.C.: Phagocytosis of microbes: insights and prospects. Trends Cell Biol. 5, 141–142 (1995). https://doi.org/10.1016/S0962-8924(00)88967-9CrossRef

27.

Owens, D.E., Peppas, N.A.: Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int. J. Pharm. 93–102 (2006). https://doi.org/10.1016/j.ijpharm.2005.10.010

28.

Underhill, D.M., Goodridge, H.S.: Information processing during phagocytosis. Nat. Rev. Immunol. 492–502 (2012). https://doi.org/10.1038/nri3244

29.

Rabinovitch, M.: Professional and non-professional phagocytes: an introduction. Trends Cell Biol. 5, 85–87 (1995). https://doi.org/10.1016/S0962-8924(00)88955-2CrossRef

30.

Dobrovolskaia, M.A., Mcneil, S.E.: Immunological properties of engineered nanomaterials. Nat. Nanotechnol. 2, 469–478 (2007)ADS

31.

Conner, S.D., Schmid, S.L.: Regulated portals of entry into the cell. Nature. 422, 37–44 (2003). https://doi.org/10.1038/nature01451

32.

Falcone, S., Cocucci, E., Podini, P., Kirchhausen, T., Clementi, E., Meldolesi, J.: Macropinocytosis: regulated coordination of endocytic and exocytic membrane traffic events. J. Cell Sci. 119, 4758–4769 (2006). https://doi.org/10.1242/jcs.03238CrossRef

33.

Mercer, J., Helenius, A.: Virus entry by macropinocytosis. Nat. Cell Biol. 510–520 (2009). https://doi.org/10.1038/ncb0509-510

34.

Kolb-Mäurer, A., Wilhelm, M., Weissinger, F., Bröcker, E.-B., Goebel, W.: Interaction of human hematopoietic stem cells with bacterial pathogens. Blood 100, 3703–3709 (2002). https://doi.org/10.1182/blood-2002-03-0898CrossRef

35.

Fiorentini, C., Falzano, L., Fabbri, A., Stringaro, A., Logozzi, M., Travaglione, S., et al.: Activation of rho GTPases by cytotoxic necrotizing factor 1 induces macropinocytosis and scavenging activity in epithelial cells. Mol. Biol. Cell 12, 2061–2073 (2001). https://doi.org/10.1091/mbc.12.7.2061CrossRef

36.

Steinman, R.M., Swanson, J.: The endocytic activity of dendritic cells. J Exp Med. United States 182, 283–288 (1995)

37.

Sallusto, F., Cella, M., Danieli, C., Lanzavecchia, A.: Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J. Exp. Med. 182, 389–400 (1995). https://doi.org/10.1084/jem.182.2.389

38.

Kerr, M.C., Teasdale, R.D.: Defining macropinocytosis. Traffic 364–371 (2009). https://doi.org/10.1111/j.1600-0854.2009.00878.x

39.

Rima, W., Sancey, L., Aloy, M.T., Armandy, E., Alcantara, G.B., Epicier, T., et al.: Internalization pathways into cancer cells of gadolinium-based radiosensitizing nanoparticles. Biomaterials 34, 181–195 (2013). https://doi.org/10.1016/j.biomaterials.2012.09.029CrossRef

40.

Kumari, S., Mg, S., Mayor, S.: Endocytosis unplugged: multiple ways to enter the cell. Cell Res. 256–275 (2010). https://doi.org/10.1038/cr.2010.19

41.

Kirchhausen, T.: Clathrin. Annu. Rev. Biochem. 69, 699–727 (2000). https://doi.org/10.1146/annurev.biochem.69.1.699CrossRef

42.

Sandvig, K., Pust, S., Skotland, T., van Deurs, B.: Clathrin-independent endocytosis: mechanisms and function. Curr. Opin. Cell Biol. 413–420 (2011). https://doi.org/10.1016/j.ceb.2011.03.007

43.

Ford, M.G.J., Mills, I.G., Peter, B.J., Vallis, Y., Praefcke, G.J.K., Evans, P.R., et al.: Curvature of clathrin-coated pits driven by epsin. Nature 419, 361–366 (2002). https://doi.org/10.1038/nature01020CrossRefADS

44.

Capraro, B.R., Shi, Z., Wu, T., Chen, Z., Dunn, J.M., Rhoades, E., et al.: Kinetics of endophilin N-BAR domain dimerization and membrane interactions. J. Biol. Chem. 288, 12533–12543 (2013). https://doi.org/10.1074/jbc.M112.435511CrossRef

45.

Tebar, F., Bohlander, S.K., Sorkin, A.: Clathrin assembly lymphoid myeloid leukemia (CALM) protein: localization in endocytic-coated pits, interactions with clathrin, and the impact of overexpression on clathrin-mediated traffic. Mol. Biol. Cell 10, 2687–2702 (1999). https://doi.org/10.1091/mbc.10.8.2687CrossRef

46.

Marsh, M., McMahon, H.T.: The structural era of endocytosis. Science 215–220 (1999). https://doi.org/10.1126/science.285.5425.215

47.

Stowell, M.H., Marks, B., Wigge, P., McMahon, H.T.: Nucleotide-dependent conformational changes in dynamin: evidence for a mechanochemical molecular spring. Nat. Cell Biol. 1, 27–32 (1999). https://doi.org/10.1038/8997CrossRef

48.

Harush-Frenkel, O., Rozentur, E., Benita, S., Altschuler, Y.: Surface charge of nanoparticles determines their endocytic and transcytotic pathway in polarized MDCK cells. Biomacromol 9, 435–443 (2008). https://doi.org/10.1021/bm700535pCrossRef

49.

Oh, P., Borgström, P., Witkiewicz, H., Li, Y., Borgström, B.J., Chrastina, A., et al.: Live dynamic imaging of caveolae pumping targeted antibody rapidly and specifically across endothelium in the lung. Nat. Biotechnol. 25, 327–337 (2007). https://doi.org/10.1038/nbt1292CrossRef

50.

Wang, Z., Tiruppathi, C., Minshall, R.D., Malik, A.B.: Size and dynamics of caveolae studied using nanoparticles in living endothelial cells. ACS Nano 3, 4110–4116 (2009). https://doi.org/10.1021/nn9012274CrossRef

51.

Hommelgaard, A.M., Roepstorff, K., Vilhardt, F., Torgersen, M.L., Sandvig, K., van Deurs, B.: Caveolae: stable membrane domains with a potential for internalization. Traffic 720–724 (2005). https://doi.org/10.1111/j.1600-0854.2005.00314.x

52.

Howes, M.T., Kirkham, M., Riches, J., Cortese, K., Walser, P.J., Simpson, F., et al.: Clathrin-independent carriers form a high capacity endocytic sorting system at the leading edge of migrating cells. J. Cell Biol. 190, 675–691 (2010). https://doi.org/10.1083/jcb.201002119CrossRef

53.

Parton, R.G., Simons, K.: The multiple faces of caveolae. Nat. Rev. Mol. Cell Biol. 185–194 (2007). https://doi.org/10.1038/nrm2122

54.

Pelkmans, L., Püntener, D., Helenius, A.: Local actin polymerization and dynamin recruitment in SV40-induced internalization of caveolae. Science (80-) 296, 535–539 (2002). https://doi.org/10.1126/science.1069784

55.

Hayer, A., Stoeber, M., Ritz, D., Engel, S., Meyer, H.H., Helenius, A.: Caveolin-1 is ubiquitinated and targeted to intralumenal vesicles in endolysosomes for degradation. J. Cell Biol. 191, 615–629 (2010). https://doi.org/10.1083/jcb.201003086CrossRef

56.

Parton, R.G., Howes, M.T.: Revisiting caveolin trafficking: the end of the caveosome. J. Cell Biol. 439–441 (2010). https://doi.org/10.1083/jcb.201009093

57.

Gratton, S.E.A., Ropp, P.A., Pohlhaus, P.D., Luft, J.C., Madden, V.J., Napier, M.E., et al.: The effect of particle design on cellular internalization pathways. Proc. Natl. Acad. Sci. 105, 11613–11618 (2008). https://doi.org/10.1073/pnas.0801763105CrossRefADS

58.

Sandvig, K., Torgersen, M.L., Raa, H.A., Van Deurs, B.: Clathrin-independent endocytosis: from nonexisting to an extreme degree of complexity. Histochem. Cell Biol. 267–276 (2008). https://doi.org/10.1007/s00418-007-0376-5

59.

Robertson, A.S., Smythe, E., Ayscough, K.R.: Functions of actin in endocytosis. Cellu. Mol. Life Sci. 2049–2065 (2009). https://doi.org/10.1007/s00018-009-0001-y

60.

Rothen-Rutishauser, B., Mühlfeld, C., Blank, F., Musso, C., Gehr, P.: Translocation of particles and inflammatory responses after exposure to fine particles and nanoparticles in an epithelial airway model. Part Fibre Toxicol. 4 (2007). https://doi.org/10.1186/1743-8977-4-9

61.

Rothen-Rutishauser, B., Schurch, S., Gehr, P.: Interaction of particles with membranes. In: Donaldson, K., Borm, P. (eds.) Particle Toxicology, pp. 139–160. CRC Press, Tyler & Francis Group, Boca Raton, FL (2007)

62.

Xu, S., Olenyuk, B.Z., Okamoto, C.T., Hamm-Alvarez, S.F.: Targeting receptor-mediated endocytotic pathways with nanoparticles: rationale and advances. Adv. Drug Deliv. Rev. 65, 121–138 (2013). https://doi.org/10.1016/j.addr.2012.09.041CrossRef

63.

Low, P.S., Kularatne, S.A.: Folate-targeted therapeutic and imaging agents for cancer. Curr. Opin. Chem. Biol. 13, 256–262 (2009). https://doi.org/10.1016/j.cbpa.2009.03.022CrossRef

64.

Muller, C., Schibli, R.: Prospects in folate receptor-targeted radionuclide therapy. Front Oncol. 3, 249 (2013). https://doi.org/10.3389/fonc.2013.00249CrossRef

65.

Xia, W., Hilgenbrink, A.R., Matteson, E.L., Lockwood, M.B., Cheng, J.X., Low, P.S.: A functional folate receptor is induced during macrophage activation and can be used to target drugs to activated macrophages. Blood 113, 438–446 (2009). https://doi.org/10.1182/blood-2008-04-150789CrossRef

66.

Ross, J.F., Wang, H., Behm, F.G., Mathew, P., Wu, M., Booth, R., et al.: Folate receptor type beta is a neutrophilic lineage marker and is differentially expressed in myeloid leukemia. Cancer 85, 348–357 (1999). http://www.ncbi.nlm.nih.gov/pubmed/10023702

67.

Low, P.S., Henne, W.A., Doorneweerd, D.D.: Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases. Acc. Chem. Res. 41, 120–129 (2008). https://doi.org/10.1021/ar7000815CrossRef

68.

Zhao, X., Li, H., Lee, R.J.: Targeted drug delivery via folate receptors. Expert Opin. Drug Deliv. 5, 309–319 (2008). https://doi.org/10.1517/17425247.5.3.309CrossRef

69.

Werner, M.E., Karve, S., Sukumar, R., Cummings, N.D., Copp, J.A., Chen, R.C., et al.: Folate-targeted nanoparticle delivery of chemo- and radiotherapeutics for the treatment of ovarian cancer peritoneal metastasis. Biomaterials 32, 8548–8554 (2011). https://doi.org/10.1016/j.biomaterials.2011.07.067CrossRef

70.

Ponka, P., Lok, C.N.: The transferrin receptor: role in health and disease. Int. J. Biochem. Cell. Biol. 31, 1111–1137 (1999). http://www.ncbi.nlm.nih.gov/pubmed/10582342

71.

Sadat Tabatabaei Mirakabad, F., Nejati-Koshki, K., Akbarzadeh, A., Yamchi, M.R., Milani, M., Zarghami, N., et al.: PLGA-based nanoparticles as cancer drug delivery systems. Asian Pac. J. Cancer Prev. 15, 517–535 (2014)

72.

Danhier, F., Feron, O., Preat, V.: To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. J. Control Release 148, 135–146 (2010). https://doi.org/10.1016/j.jconrel.2010.08.027CrossRef

73.

van der Meel, R., Vehmeijer, L.J., Kok, R.J., Storm, G., van Gaal, E.V.: Ligand-targeted particulate nanomedicines undergoing clinical evaluation: current status. Adv. Drug Deliv. Rev. 65, 1284–1298 (2013). https://doi.org/10.1016/j.addr.2013.08.012CrossRef

74.

Mirghani, H., Amen, F., Moreau, F., Guigay, J., Hartl, D.M., Lacau St Guily, J.: Oropharyngeal cancers: relationship between epidermal growth factor receptor alterations and human papillomavirus status. Eur. J. Cancer 50, 1100–1111 (2014). https://doi.org/10.1016/j.ejca.2013.12.018

75.

Holbro, T., Civenni, G., Hynes, N.E.: The ErbB receptors and their role in cancer progression. Exp. Cell Res. 284, 99–110 (2003). http://www.ncbi.nlm.nih.gov/pubmed/12648469

76.

Lurje, G., Lenz, H.J.: EGFR signaling and drug discovery. Oncology 77, 400–410 (2009). https://doi.org/10.1159/000279388CrossRef

77.

Harris, R.C., Chung, E., Coffey, R.J.: EGF receptor ligands. Exp. Cell Res. 284, 2–13 (2003). http://www.ncbi.nlm.nih.gov/pubmed/12648462

78.

Tseng, C.L., Su, W.Y., Yen, K.C., Yang, K.C., Lin, F.H.: The use of biotinylated-EGF-modified gelatin nanoparticle carrier to enhance cisplatin accumulation in cancerous lungs via inhalation. Biomaterials 30, 3476–3485 (2009). https://doi.org/10.1016/j.biomaterials.2009.03.010CrossRef

79.

Rajasekaran, A.K., Anilkumar, G., Christiansen, J.J.: Is prostate-specific membrane antigen a multifunctional protein? Am. J. Physiol. Cell Physiol. 288, C975–C981 (2005). https://doi.org/10.1152/ajpcell.00506.2004CrossRef

80.

Schulke, N., Varlamova, O.A., Donovan, G.P., Ma, D., Gardner, J.P., Morrissey, D.M., et al.: The homodimer of prostate-specific membrane antigen is a functional target for cancer therapy. Proc. Natl. Acad. Sci. U.S.A. 100, 12590–12595 (2003). https://doi.org/10.1073/pnas.1735443100CrossRefADS

81.

Hrkach, J., Von Hoff, D., Mukkaram Ali, M., Andrianova, E., Auer, J., Campbell, T., et al.: Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile. Sci. Trans. Med. 4, 128ra39 (2012). https://doi.org/10.1126/scitranslmed.3003651

82.

Tucker, G.C.: Integrins: molecular targets in cancer therapy. Curr. Oncol. Rep. 8, 96–103 (2006). http://www.ncbi.nlm.nih.gov/pubmed/16507218

83.

Gottschalk, K.E., Kessler, H.: The structures of integrins and integrin-ligand complexes: implications for drug design and signal transduction. Angew. Chem. Int. Ed. Engl. 41, 3767–3774 (2002). https://doi.org/10.1002/1521-3773(20021018)41:20%3c3767:AID-ANIE3767%3e3.0.CO;2-TCrossRef

84.

Eliceiri, B.P., Cheresh, D.A.: Role of alpha v integrins during angiogenesis. Cancer J. 6(Suppl 3), S245–9 (2000). http://www.ncbi.nlm.nih.gov/pubmed/10874494

85.

Brooks, P.C., Stromblad, S., Sanders, L.C., von Schalscha, T.L., Aimes, R.T., Stetler-Stevenson, W.G., et al.: Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alphavbeta3. Cell 85, 683–693 (1996). http://www.ncbi.nlm.nih.gov/pubmed/8646777

86.

Liu, S.: Radiolabeled cyclic RGD peptides as integrin alpha(v)beta(3)-targeted radiotracers: maximizing binding affinity via bivalency. Bioconjug. Chem. 20, 2199–2213 (2009). https://doi.org/10.1021/bc900167cCrossRef

87.

Auzzas, L., Zanardi, F., Battistini, L., Burreddu, P., Carta, P., Rassu, G., et al.: Targeting alphavbeta3 integrin: design and applications of mono- and multifunctional RGD-based peptides and semipeptides. Curr. Med. Chem. 17, 1255–1299 (2010). http://www.ncbi.nlm.nih.gov/pubmed/20166941

88.

Graf, N., Bielenberg, D.R., Kolishetti, N., Muus, C., Banyard, J., Farokhzad, O.C., et al.: alpha(V)beta(3) integrin-targeted PLGA-PEG nanoparticles for enhanced anti-tumor efficacy of a Pt(IV) prodrug. ACS Nano 6, 4530–4539 (2012). https://doi.org/10.1021/nn301148eCrossRef

89.

Brambell, F.W.: The transmission of immune globulins from the mother to the foetal and newborn young. Proc. Nutr. Soc. 28, 35–41 (1969). http://www.ncbi.nlm.nih.gov/pubmed/4182340

90.

Pridgen, E.M., Alexis, F., Kuo, T.T., Levy-Nissenbaum, E., Karnik, R., Blumberg, R.S., et al.: Transepithelial transport of Fc-targeted nanoparticles by the neonatal fc receptor for oral delivery. Sci. Transl. Med. 5, 213ra167 (2013). https://doi.org/10.1126/scitranslmed.3007049

91.

Goldberg, M., Gomez-Orellana, I.: Challenges for the oral delivery of macromolecules. Nat. Rev. Drug Discov. 2, 289–295 (2003). https://doi.org/10.1038/nrd1067CrossRef

92.

Borner, M.M., Schoffski, P., de Wit, R., Caponigro, F., Comella, G., Sulkes, A., et al.: Patient preference and pharmacokinetics of oral modulated UFT versus intravenous fluorouracil and leucovorin: a randomised crossover trial in advanced colorectal cancer. Eur. J. Cancer 38, 349–358 (2002). http://www.ncbi.nlm.nih.gov/pubmed/11818199

93.

Priem, B., Tian, C., Tang, J., Zhao, Y., Mulder, W.J.: Fluorescent nanoparticles for the accurate detection of drug delivery. Expert Opin. Drug Deliv. 12, 1881–1894 (2015). https://doi.org/10.1517/17425247.2015.1074567CrossRef

94.

Wei, Q., Qi, H., Luo, W., Tseng, D., Ki, S.J., Wan, Z., et al.: Fluorescent imaging of single nanoparticles and viruses on a smart phone. ACS Nano 7, 9147–9155 (2013). https://doi.org/10.1021/nn4037706CrossRef

95.

Jin, S., Hu, Y., Gu, Z., Liu, L., Wu, H.-C.: Application of quantum dots in biological imaging. J. Nanomater. 2011, 1–13 (2011). https://doi.org/10.1155/2011/834139CrossRef

96.

He, X., Ma, N.: An overview of recent advances in quantum dots for biomedical applications. Coll. Surf. B Biointerfaces 124, 118–131 (2014). https://doi.org/10.1016/j.colsurfb.2014.06.002CrossRef

97.

Michalet, X., Pinaud, F.F., Bentolila, L.A., Tsay, J.M., Doose, S., Li, J.J., et al.: Quantum dots for live cells, in vivo imaging, and diagnostics. Science 307, 538–544 (2005). https://doi.org/10.1126/science.1104274CrossRefADS

98.

Bagalkot, V., Zhang, L., Levy-Nissenbaum, E., Jon, S., Kantoff, P.W., Langery, R., et al.: Quantum dot-aptamer conjugates for synchronous cancer imaging, therapy, and sensing of drug delivery based on Bi-fluorescence resonance energy transfer. Nano Lett. 7, 3065–3070 (2007). https://doi.org/10.1021/nl071546nCrossRefADS

99.

Fontes, A., de Lira, R.B., Seabra, M.A.B.L., da Silva, T.G., Castro Neto, A.G., Santos, B.S.: Quantum dots in biomedical research, biomedical engineering—technical applications in medicine [Internet]. In: Hudak, R. (ed.) InTech. https://www.intechopen.com/books/biomedical-engineering-technical-applications-in-medicine/quantum-dots-in-biomedical-research (2012)

100.

England, C.G., Huang, J.S., James, K.T., Zhang, G., Gobin, A., Frieboes, H.B.: Detection of phosphatidylcholine-coated gold nanoparticles in orthotopic pancreatic adenocarcinoma using hyperspectral imaging. PLoS One 10 (2015). https://doi.org/10.1371/journal.pone.0129172

101.

Guggenheim, E.J., Khan, A., Pike, J., Chang, L., Lynch, I., Rappoport JZ. Comparison of confocal and super-resolution reflectance imaging of metal oxide nanoparticles. PLoS One 11 (2016). https://doi.org/10.1371/journal.pone.0159980

102.

Repenko, T., Rix, A., Ludwanowski, S., Go, D., Kiessling, F., Lederle, W., et al.: Bio-degradable highly fluorescent conjugated polymer nanoparticles for bio-medical imaging applications. Nat. Commun. 8 (2017). https://doi.org/10.1038/s41467-017-00545-0

103.

Wolfbeis, O.S.: An overview of nanoparticles commonly used in fluorescent bioimaging. Chem. Soc. Rev. 44, 4743–4768 (2015). https://doi.org/10.1039/C4CS00392FCrossRef

104.

Chen, X., Cui, J., Sun, H., Mullner, M., Yan, Y., Noi, K.F., et al.: Analysing intracellular deformation of polymer capsules using structured illumination microscopy. Nanoscale 8, 11924–11931 (2016). https://doi.org/10.1039/c6nr02151dCrossRefADS

105.

Fytianos, K., Rodriguez-Lorenzo, L., Clift, M.J.D., Blank, F., Vanhecke, D., von Garnier, C., et al.: Uptake efficiency of surface modified gold nanoparticles does not correlate with functional changes and cytokine secretion in human dendritic cells in vitro. Nanomed. Nanotechnol. Biol. Med. 11 (2015). https://doi.org/10.1016/j.nano.2014.11.004

106.

Lehmann, A.D., Parak, W.J., Zhang, F., Ali, Z., Röcker, C., Nienhaus, G.U., et al.: Fluorescent-magnetic hybrid nanoparticles induce a dose-dependent increase in proinflammatory response in lung cells in vitro correlated with intracellular localization. Small 6, 753–762 (2010)

107.

Blom, R.A.M., Amacker, M., Moser, C., van Dijk, R.M., Bonetti, R., Seydoux, E., et al.: Virosome-bound antigen enhances DC-dependent specific CD4⁺T cell stimulation, inducing a Th1 and Treg profile in vitro. Nanomed. Nanotechnol. Biol. Med. 13 (2017). https://doi.org/10.1016/j.nano.2017.02.004

108.

Seydoux, E., Rothen-Rutishauser, B., Nita, I.M., Balog, S., Gazdhar, A., Stumbles, P.A., et al.: Size-dependent accumulation of particles in lysosomes modulates dendritic cell function through impaired antigen degradation. Int. J. Nanomed. 9 (2014). https://doi.org/10.2147/ijn.s64353

109.

Hemmerich, P.H., von Mikecz, A.H.: Defining the subcellular interface of nanoparticles by live-cell imaging. PLoS One 8 (2013). https://doi.org/10.1371/journal.pone.0062018

110.

De Los, S.C., Chang, C.-W., Mycek, M.-A., Cardullo, R.A.: FRAP, FLIM, and FRET: detection and analysis of cellular dynamics on a molecular scale using fluorescence microscopy. Mol. Reprod. Dev. 82, 587–604 (2015). https://doi.org/10.1002/mrd.22501CrossRef

111.

Basuki, J.S., Duong, H.T.T., Macmillan, A., Erlich, R.B., Esser, L., Akerfeldt, M.C., et al.: Using fluorescence lifetime imaging microscopy to monitor theranostic nanoparticle uptake and intracellular doxorubicin release. ACS Nano 7, 10175–10189 (2013). https://doi.org/10.1021/nn404407gCrossRef

112.

Welsher, K., Yang, H.: Multi-resolution 3D visualization of the early stages of cellular uptake of peptide-coated nanoparticles. Nat. Nanotechnol. 9, 198–203 (2014). https://doi.org/10.1038/nnano.2014.12CrossRefADS

113.

Van Der Zwaag, D., Vanparijs, N., Wijnands, S., De Rycke, R., De Geest, B.G., Albertazzi, L.: Super resolution imaging of nanoparticles cellular uptake and trafficking. ACS Appl. Mater. Interfaces 8, 6391–6399 (2016). https://doi.org/10.1021/acsami.6b00811CrossRef

114.

Bon, P., Bourg, N., Lécart, S., Monneret, S., Fort, E., Wenger, J., et al.: Three-dimensional nanometre localization of nanoparticles to enhance super-resolution microscopy. Nat. Commun. 6 (2015). https://doi.org/10.1038/ncomms8764

115.

Peuschel, H., Ruckelshausen, T., Cavelius, C., Kraegeloh, A.: Quantification of internalized silica nanoparticles via STED microscopy. Biomed. Res. Int. 2015 (2015). https://doi.org/10.1155/2015/961208

116.

Rodriguez-Lorenzo, L., Fytianos, K., Blank, F., Von Garnier, C., Rothen-Rutishauser, B., Petri-Fink, A.: Fluorescence-encoded gold nanoparticles: library design and modulation of cellular uptake into dendritic cells. Small 10, 1341–1350 (2014). https://doi.org/10.1002/smll.201302889CrossRef

117.

Clift, M.J.D., Fytianos, K., Vanhecke, D., Hočevar, S., Petri-Fink, A., Rothen-Rutishauser, B.: A novel technique to determine the cell type specific response within an in vitro co-culture model via multi-colour flow cytometry. Sci. Rep. 7, 434 (2017). https://doi.org/10.1038/s41598-017-00369-4CrossRefADS

118.

Mills, N., Rnqvist, H.T., Gonzalez, M., Vink, E., Robinson, S., Soderberg, S., et al.: Ischaemic and thrombotic effects of dilute diesel exhaust inhalation in patients with coronary heart disease: mechanisms for the adverse cardiovascular effects of air pollution. Heart 93, A9–A9 (2007)

119.

Clark, R.T.: Imaging flow cytometry enhances particle detection sensitivity for extracellular vesicle analysis. Nat. Methods. Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved; 12 (2015). http://dx.doi.org/10.1038/nmeth.f.380

120.

Vanhecke, D., Rodriguez-Lorenzo, L., Clift, M.J.D., Blank, F., Petri-Fink, A., Rothen-Rutishauser, B.: Quantification of nanoparticles at the single-cell level: an overview about state-of-the-art techniques and their limitations. Nanomedicine 9 (2014). https://doi.org/10.2217/nnm.14.108

Title: Cellular Uptake Mechanisms and Detection of Nanoparticle Uptake by Advanced Imaging Methods
Authors: Kleanthis Fytianos
Fabian Blank
Loretta Müller
Publisher: Springer International Publishing
Book: Biological Responses to Nanoscale Particles
Print ISBN: 978-3-030-12460-1

Electronic ISBN: 978-3-030-12461-8

Copyright Year: 2019
DOI: https://doi.org/10.1007/978-3-030-12461-8_8

Springer Professional

Abstract

Please log in to get access to your license.

Dont have a licence yet? Then find out more about our products and how to get one now:

Springer Professional "Wirtschaft+Technik"

Springer Professional "Technik"

Premium Partners